Giant cell (Hecht's) pneumonia is typically associated with which of the following viruses?
A 60-year-old man has had worsening dyspnea and nonproductive cough over the past 2 years. On physical examination, his temperature is 37.4°C, pulse is 74/min, respirations are 20/min, and blood pressure is 110/70 mm Hg. A chest radiograph shows extensive interstitial lung disease and a prominent right-sided heart border. Spirometry reveals decreased FEV1 and FVC. His pulmonary disease is most likely caused by exposure to which of the following?
An elderly male with a history of 60-pack-year of smoking is diagnosed with carcinoma lung. Histological evaluation of the tumor revealed small, highly mitotic cells with scant cytoplasm and hyperchromatic nuclei. Which of the following clinical presentations might occur in the patient during the course of his illness?
All of the following produce cavitating nodules in the lung except?
A 40-year-old male patient presents with a chronic history of breathlessness and intermittent jaundice. He denies smoking and alcohol abuse. Lung and liver specimens revealed specific findings. Which of the following pooled plasma human concentrates has been approved for this condition?
Which of the following is NOT secreted by small cell carcinoma of the lung?
Pleural calcification is seen commonly in which condition?
All of the following are true regarding oat cell carcinoma of the lung, except:
A 60-year-old chronic smoker presented with gradual and slowly progressive shortness of breath for 5 months, along with dry cough, malaise, and fatigue. There was no history of hemoptysis, chest pain, or occupational exposure. Chest X-ray and HRCT chest were performed. Lung biopsy was planned. Which of the following drugs has been recently approved for this condition?
Smoking is generally not associated as a risk factor with which of the following conditions?
Explanation: **Explanation:** **Giant cell (Hecht's) pneumonia** is a severe interstitial pneumonia characterized by the presence of multinucleated giant cells within the alveolar spaces. 1. **Why Measles is correct:** Measles virus (Rubeola) is the causative agent. In immunocompromised individuals (such as those with leukemia or HIV), the virus fails to produce the typical rash but instead causes a fatal interstitial pneumonia [1]. The hallmark histological finding is the **Warthin-Finkeldey giant cell**, which contains characteristic **eosinophilic intranuclear and intracytoplasmic inclusion bodies**. These cells are formed by the fusion of infected respiratory epithelial cells. 2. **Why the other options are incorrect:** * **Cytomegalovirus (CMV):** While CMV causes interstitial pneumonia in immunocompromised hosts [2], it is characterized by "Owl’s eye" appearances (large cells with a single, massive basophilic intranuclear inclusion surrounded by a clear halo), not Hecht’s giant cells. * **Malaria parasite:** Malaria (specifically *P. falciparum*) can cause Acute Respiratory Distress Syndrome (ARDS) due to capillary leakage, but it does not produce giant cell pneumonia. * **Pneumocystis jirovecii:** This fungus causes pneumonia in HIV patients, typically presenting with a "crushed ping-pong ball" appearance on Silver stain (GMS) and intra-alveolar foamy/pink exudates [2], rather than viral giant cells. **High-Yield Pearls for NEET-PG:** * **Warthin-Finkeldey Cells:** Pathognomonic for Measles; found in lymphoid tissues (tonsils/nodes) and lungs. * **Koplik Spots:** The clinical hallmark of Measles (small white spots on buccal mucosa). * **Vitamin A:** Supplementation reduces morbidity and mortality in children with Measles. * **SSPE (Subacute Sclerosing Panencephalitis):** A late neurological complication of Measles occurring years after the initial infection. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 362-363. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 318-319.
Explanation: **Explanation:** The clinical presentation of chronic, progressive dyspnea, nonproductive cough, and interstitial lung disease (ILD) on imaging indicates a **Restrictive Lung Disease**, specifically a pneumoconiosis. **Why Silica crystals is correct:** Silicosis is a chronic occupational lung disease caused by inhaling crystalline silica [1]. It leads to a fibrotic restrictive pattern characterized by decreased FEV1 and FVC (with a normal or increased FEV1/FVC ratio). The "prominent right-sided heart border" signifies **Cor Pulmonale** (right ventricular hypertrophy/failure), a common late-stage complication of chronic fibrotic lung diseases due to pulmonary hypertension [2]. Pathologically, silica triggers macrophages to release inflammatory cytokines (IL-1, TNF), leading to the formation of characteristic silicotic nodules and progressive massive fibrosis. **Why incorrect options are wrong:** * **Carbon monoxide:** This is an odorless gas that causes acute toxicity by binding to hemoglobin (forming carboxyhemoglobin), leading to tissue hypoxia. It does not cause chronic interstitial fibrosis. * **Fungal hyphae:** While certain fungi can cause Hypersensitivity Pneumonitis (e.g., Farmer’s lung) or chronic infections, they typically present with acute systemic symptoms (fever, chills) or specific radiological findings like "fungus balls" (Aspergilloma), rather than classic progressive ILD leading to Cor Pulmonale. * **Plant pollen:** This is a common allergen that triggers Type I hypersensitivity (Allergic Rhinitis or Extrinsic Asthma). Asthma is an **obstructive** lung disease, not a restrictive interstitial disease. **NEET-PG High-Yield Pearls:** * **Radiology:** Silicosis classically shows "eggshell calcification" of hilar lymph nodes. * **Location:** Silicosis primarily affects the **upper lobes** (unlike Asbestosis, which affects lower lobes). * **Association:** Silicosis significantly increases the risk of **Tuberculosis (TB)** because silica impairs macrophage function (phagolysosome formation) [1]. * **Birefringence:** Under polarized light, silica particles appear as weakly birefringent crystals. [1] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 697-698. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 691-692.
Explanation: **Explanation:** The clinical presentation and histological findings (small cells, scant cytoplasm, hyperchromatic nuclei, and high mitotic activity) are pathognomonic for **Small Cell Lung Carcinoma (SCLC)** [1]. SCLC is a neuroendocrine tumor strongly associated with heavy smoking and is notorious for causing **Paraneoplastic Syndromes** [2]. **1. Why Option A is Correct:** SCLC frequently secretes ectopic **Adrenocorticotropic Hormone (ACTH)**. Excess ACTH stimulates the adrenal cortex to produce high levels of cortisol, leading to **Ectopic Cushing Syndrome** [3]. This manifests as central obesity (moon face, buffalo hump) and thin extremities (due to muscle wasting from protein catabolism). **2. Why Incorrect Options are Wrong:** * **Option B:** While SCLC can rarely cause gynecomastia (via hCG secretion), "increased hair all over the body" is not a standard presentation. Cushing syndrome typically causes hirsutism in females, not generalized hypertrichosis in males [3]. * **Option C:** While chronic illness affects mental health, "psychosocial changes" is too vague and not a specific paraneoplastic manifestation of SCLC. * **Option D:** SCLC is more likely to cause **SIADH** (leading to hyponatremia) or Lambert-Eaton Syndrome, rather than chronic anemia requiring frequent transfusions. **Clinical Pearls for NEET-PG:** * **SCLC Associations:** SIADH (most common), Ectopic ACTH, and Lambert-Eaton Myasthenic Syndrome (LEMS) [2]. * **Histology:** Look for "Azzopardi effect" (DNA staining of vessel walls) and "molding" of nuclei [1]. * **Markers:** Positive for Chromogranin A, Synaptophysin, and CD56 [1]. * **Squamous Cell Carcinoma (SCC):** Associated with PTHrP secretion leading to **Hypercalcemia**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 337-338. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 725-727. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1127-1129.
Explanation: **Explanation:** The correct answer is **Hamartoma**. In pulmonary pathology, a cavitation occurs when the center of a nodule or mass undergoes necrosis and is expelled through the bronchial tree, leaving an air-filled space. **1. Why Hamartoma is the correct answer:** A pulmonary hamartoma is a **benign** neoplasm composed of disorganized native lung tissues (cartilage, fat, and epithelium) [1]. These lesions are typically slow-growing, solid, and well-circumscribed. They do not undergo central necrosis or abscess formation; therefore, they **do not cavitate** [1]. On imaging, they are classic for "popcorn calcification." **2. Analysis of incorrect options (Conditions that DO cavitate):** * **Squamous Cell Carcinoma (SCC):** This is the most common lung cancer to cavitate (approx. 10-15% of cases). The tumours are usually central in location and frequently cavitate [2]. Rapid growth often outstrips the blood supply, leading to central ischemic necrosis. * **Caplan’s Syndrome:** This is the combination of Rheumatoid Arthritis and Coal Worker’s Pneumoconiosis. It presents with large necrobiotic nodules (rheumatoid nodules) in the lung which frequently undergo central cavitation [3]. * **Silicosis:** While simple silicosis presents with solid nodules, **Progressive Massive Fibrosis (PMF)** in advanced silicosis can lead to cavitation due to ischemia or associated tuberculosis (Silicotuberculosis). **Clinical Pearls for NEET-PG:** * **Mnemonic for Cavitating Lung Lesions (CAVITY):** **C**ancer (SCC), **A**utoimmune (Wegener’s/GPA, Rheumatoid nodules), **V**ascular (Septic emboli), **I**nfection (TB, Fungal, Abscess), **T**rauma, **Y**outh (CPAM/Congenital). * **Hamartoma Key Sign:** "Popcorn calcification" on HRCT. * **SCC Key Sign:** Central location, smoking association, and PTHrP secretion (Hypercalcemia) [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 727-728. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 336-337. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 333-334.
Explanation: ### Explanation **Diagnosis: Alpha-1 Antitrypsin Deficiency (AATD)** The clinical presentation of a non-smoker with chronic breathlessness (suggestive of **panacinar emphysema**) and intermittent jaundice (suggestive of **liver cirrhosis**) is a classic "high-yield" triad for Alpha-1 Antitrypsin Deficiency [1]. In this genetic condition, the misfolded protein accumulates in the liver (PAS-positive, diastase-resistant globules) and fails to reach the lungs, leading to unchecked neutrophil elastase activity and alveolar destruction [2]. **Why Option C is Correct:** **Zemaira** (often misspelled in exams as Zaimira) is a highly purified, sterile, stable lyophilized preparation of pooled human Alpha-1 Proteinase Inhibitor (A1-PI). It is FDA-approved for chronic augmentation therapy in individuals with clinically evident emphysema due to severe hereditary AATD [3]. It works by increasing and maintaining the serum levels of AAT, thereby protecting the lung parenchyma. **Why Options A and B are Incorrect:** * **Prolastin-C** and **Aralast NP** are also FDA-approved pooled human plasma concentrates used for the same condition. * **Note on the Question Structure:** In many competitive exams like NEET-PG, if the options include specific brand names of augmentation therapy, the "Correct" answer often depends on the most recent pharmacological updates or specific clinical trial mentions in standard textbooks (like Harrison or Robbins). However, technically, **all three (Prolastin, Aralast, and Zemaira)** are approved. If the question marks "Zaimira" as the specific correct choice, it likely refers to its high purity profile or a specific textbook reference used by the examiner. *Note: In a standard "All of the above" scenario, Option D would be the most scientifically accurate.* **Clinical Pearls for NEET-PG:** * **Genetics:** Mutation in the *SERPINA1* gene; **PiZZ** is the most severe phenotype [2]. * **Lung Pathology:** Panacinar emphysema, most severe at the **lower lobes** [3]. * **Liver Pathology:** PAS-positive, diastase-resistant eosinophilic cytoplasmic globules [1]. * **Management:** Smoking cessation is the most critical intervention; Augmentation therapy (Zemaira, Prolastin, Aralast) is the specific medical treatment. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 856-858. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 683-684. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 684-685.
Explanation: ### Explanation **Small Cell Carcinoma of the Lung (SCLC)** is a highly aggressive neuroendocrine tumor derived from **Kulchitsky cells** (APUD cells) [2]. Because of its neuroendocrine origin, it is notorious for producing various ectopic hormones and causing paraneoplastic syndromes [1]. **Why Noradrenaline is the correct answer:** While SCLC can secrete various amines and peptides, it does **not** typically secrete **Noradrenaline**. Noradrenaline (and Adrenaline) are catecholamines primarily secreted by tumors of the adrenal medulla (Pheochromocytoma) or sympathetic nervous system (Neuroblastoma). **Analysis of Incorrect Options:** * **Antidiuretic hormone (ADH):** SCLC is the most common cause of ectopic ADH production, leading to **SIADH** (Syndrome of Inappropriate Antidiuretic Hormone), characterized by hyponatremia [1]. * **Adrenocorticotropic hormone (ACTH):** Ectopic ACTH secretion by SCLC leads to **Cushing Syndrome** [1]. This typically presents with rapid onset hypertension, hypokalemia, and hyperglycemia rather than the classic "buffalo hump" seen in pituitary-driven Cushing’s. * **5-Hydroxytryptamine (5-HT/Serotonin):** As a neuroendocrine tumor, SCLC can secrete serotonin, occasionally leading to **Carcinoid Syndrome** (though this is more common with bronchial carcinoids). **High-Yield Clinical Pearls for NEET-PG:** * **Origin:** Central location (perihilar), strongly associated with smoking [2]. * **Genetics:** Nearly 100% show **TP53** and **RB1** mutations. * **Markers:** Positive for Chromogranin A, Synaptophysin, and CD56 [2]. * **Lambert-Eaton Myasthenic Syndrome (LEMS):** Another high-yield paraneoplastic syndrome associated with SCLC, caused by antibodies against voltage-gated calcium channels. * **Treatment:** Usually managed with chemotherapy/radiotherapy rather than surgery due to early metastasis [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 724-727. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 336-338.
Explanation: **Explanation:** **Asbestosis** is the correct answer because the most common manifestation of asbestos exposure is the development of **pleural plaques**. These are well-circumscribed areas of dense collagen, often occurring on the parietal pleura (especially over the diaphragm and rib cage) [1]. Over time, these plaques frequently undergo **calcification**, which is a classic radiologic hallmark of asbestos exposure (often appearing as "holly leaf" shadows on a chest X-ray) [1]. **Analysis of Incorrect Options:** * **Silicosis:** Primarily affects the lung parenchyma, characterized by silicotic nodules in the upper lobes. While it causes "eggshell calcification" of the **hilar lymph nodes**, it does not typically cause pleural calcification. * **Hyperparathyroidism:** This leads to **metastatic calcification** due to hypercalcemia. While it can affect the lungs (alveolar walls), it involves the interstitial tissue and blood vessels rather than localized pleural thickening and calcification [2]. * **Bronchogenic Carcinoma:** While asbestos exposure increases the risk of this malignancy, the cancer itself presents as a mass lesion or obstructive pneumonia, not as diffuse or localized pleural calcification [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Pleural Plaques:** The most common asbestos-related finding; they do *not* contain asbestos bodies and are *not* precursors to mesothelioma [1]. * **Ferruginous Bodies:** Golden-brown, fusiform/beaded rods with a translucent center (asbestos core) coated with iron-containing protein. * **Prussian Blue Stain:** Used to highlight the iron coating of asbestos bodies. * **Risk Factor:** Asbestos exposure increases the risk of Bronchogenic Carcinoma more than Mesothelioma, but it is the *only* known risk factor for Mesothelioma [1]. Smoking acts synergistically with asbestos to exponentially increase the risk of Bronchogenic Carcinoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 698-699. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77.
Explanation: **Explanation:** **Oat cell carcinoma**, also known as **Small Cell Lung Carcinoma (SCLC)**, is a highly aggressive neuroendocrine tumor [1]. 1. **Why Option A is the correct answer (The False Statement):** Oat cell carcinoma is **not** a variant of large cell carcinoma. In the WHO classification, Small Cell Carcinoma and Large Cell Neuroendocrine Carcinoma are distinct histological entities [1]. Oat cell carcinoma is characterized by scant cytoplasm, ill-defined cell borders, finely granular chromatin (salt-and-pepper appearance), and absent or inconspicuous nucleoli [1]. In contrast, Large Cell Carcinoma consists of large, atypical cells with prominent nucleoli [1]. 2. **Analysis of other options:** * **Option B (Chemotherapy):** SCLC is highly sensitive to chemotherapy and radiotherapy due to its high growth fraction [2]. While it has a poor long-term prognosis due to early metastasis, it shows a dramatic initial response to treatment [2]. * **Option C (Paraneoplastic syndromes):** SCLC is the lung cancer most frequently associated with paraneoplastic syndromes because of its neuroendocrine origin [2]. * **Option D (SIADH):** SCLC is the most common cause of ectopic ADH secretion, leading to the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) and hyponatremia. **High-Yield Clinical Pearls for NEET-PG:** * **Origin:** Derived from **Kulchitsky cells** (neuroendocrine cells). * **Markers:** Positive for Chromogranin A, Synaptophysin, and CD56 [1]. * **Genetics:** Strongest association with smoking; almost always involves **RB1** and **TP53** mutations. * **Azzopardi Effect:** Basophilic staining of vascular walls due to DNA encrustation from necrotic tumor cells. * **Other Paraneoplastic Syndromes:** Ectopic ACTH (Cushing syndrome) and Lambert-Eaton Myasthenic Syndrome. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 337-338. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 720-727.
Explanation: ### Explanation **Diagnosis:** The clinical presentation of a 60-year-old chronic smoker with progressive dyspnea, dry cough, and constitutional symptoms (malaise, fatigue) in the absence of occupational exposure strongly suggests **Idiopathic Pulmonary Fibrosis (IPF)**. IPF is characterized by chronic, progressive fibrosing interstitial pneumonia, typically showing a "Usual Interstitial Pneumonia" (UIP) pattern on HRCT [1]. **Why Nintedanib is Correct:** **Nintedanib** is a potent **tyrosine kinase inhibitor (TKI)** that targets multiple receptors involved in the pathogenesis of pulmonary fibrosis, specifically: * Platelet-derived growth factor receptor (PDGFR) * Fibroblast growth factor receptor (FGFR) * Vascular endothelial growth factor receptor (VEGFR) By inhibiting these pathways, it reduces fibroblast proliferation, migration, and differentiation, thereby slowing the decline of lung function in patients with IPF and other progressive fibrosing interstitial lung diseases (ILDs). **Analysis of Incorrect Options:** * **Sorafenib:** A multi-kinase inhibitor used primarily for Hepatocellular Carcinoma (HCC) and Renal Cell Carcinoma (RCC). * **Sunitinib:** A TKI used in the treatment of RCC and Gastrointestinal Stromal Tumors (GIST). * **Erlotinib:** An EGFR tyrosine kinase inhibitor used specifically for Non-Small Cell Lung Cancer (NSCLC) with EGFR mutations, not for fibrotic lung disease. **Clinical Pearls for NEET-PG:** * **Pirfenidone** is the other major anti-fibrotic drug approved for IPF; it acts by inhibiting TGF-β induced collagen synthesis. * **HRCT Hallmark of IPF:** Subpleural, basal-predominant reticular opacities with **honeycombing** and traction bronchiectasis [1]. * **Histopathology:** Characterized by **"Temporal Heterogeneity"** (fibroblastic foci mixed with normal lung and old dense scars). * **Smoking** is the most significant environmental risk factor for IPF [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 691-693.
Explanation: ### Explanation The correct answer is **Respiratory Bronchiolitis (RB)**. #### Why Respiratory Bronchiolitis is the Correct Answer (The Concept) This question is a classic "except" style question that tests your understanding of the direct causal links between smoking and lung pathology. While the name sounds generic, **Respiratory Bronchiolitis** is actually a histopathologic finding seen in virtually **all active smokers**. It is characterized by the accumulation of pigmented macrophages (smoker's macrophages) within the respiratory bronchioles [1]. Therefore, smoking is the **primary cause**, not a condition "not associated" with it. *Note: There appears to be a discrepancy in the provided key. In standard pathology (Robbins), RB is the quintessential smoking-related interstitial lung disease. If the question intended to find a condition **not** associated with smoking, **Bronchiectasis** is the more appropriate choice, as its primary drivers are chronic infections, cystic fibrosis, or ciliary dyskinesia, rather than tobacco smoke.* #### Analysis of Other Options * **Small Cell Carcinoma:** This has the strongest association with smoking (>95% of patients are smokers). It is a neuroendocrine tumor highly linked to tobacco carcinogens. * **Emphysema:** Smoking is the leading cause of centriacinar emphysema [2]. It triggers an imbalance in the protease-antiprotease mechanism, leading to alveolar wall destruction [3]. * **Bronchiectasis:** While smoking can aggravate chronic bronchitis (which may coexist), it is not a direct primary risk factor for the structural permanent dilation of bronchi seen in bronchiectasis [4]. #### NEET-PG High-Yield Pearls * **RB-ILD:** When Respiratory Bronchiolitis presents with clinical symptoms and restrictive lung physiology, it is termed Respiratory Bronchiolitis-Associated Interstitial Lung Disease (RB-ILD). * **Smoker’s Macrophages:** These contain "dusty" brown cytoplasmic pigment and are the hallmark of smoking-related lung injury [1]. * **Strongest Smoking Links:** Small cell carcinoma and Squamous cell carcinoma (the "S" cancers are Central and Smoking-related). * **Weakest Smoking Link:** Adenocarcinoma is the most common lung cancer in non-smokers (though still common in smokers). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 702-703. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 326-327. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 684-685. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 681-683.
Congenital Anomalies
Practice Questions
Atelectasis and Acute Lung Injury
Practice Questions
Obstructive Pulmonary Diseases
Practice Questions
Restrictive Pulmonary Diseases
Practice Questions
Lung Infections
Practice Questions
Pulmonary Vascular Diseases
Practice Questions
Lung Tumors
Practice Questions
Pleural Diseases
Practice Questions
Interstitial Lung Diseases
Practice Questions
Occupational Lung Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free